HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
MiningAndMetalMovers.com is also looking into these tickers AVY, CMC, MERC, LIN and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
AmerisourceBergen
Symbol: ABC
Recent ABC Price: $148.22
Average Analyst Price Target: $173.70 (17.19%)
ABC Market Cap: $30.49B
Expected Ex-Dividend Date for ABC stock: Aug 12 2022
Expected Payment Date for ABC stock: Aug 29 2022
Expected Dividend & Yield for ABC stock: 1.26%
Recent Analyst Action: Lisa Gill, analyst at J.P. Morgan, reiterates coverage on AmerisourceBergen (ABC) stock in the Healthcare sector with a Buy rating and a price target of $ 191 (1 week ago).
Click for full story on ABC stock >>--------------------------------------------------------------------------
Bio-Techne
Symbol: TECH
Recent TECH Price: $374.43
Average Analyst Price Target: $494.43 (32.05%)
TECH Market Cap: $14.91B
Expected Ex-Dividend Date for TECH stock: Aug 12 2022
Expected Payment Date for TECH stock: Aug 29 2022
Expected Dividend & Yield for TECH stock: 0.35%
Recent Analyst Action: Jacob Johnson, analyst at Stephens, reiterates coverage on Bio-Techne (TECH) stock in the Healthcare sector with a Buy rating and a price target of $ 480 (1 week ago).
Click for full story on TECH stock >>--------------------------------------------------------------------------
Chemed
Symbol: CHE
Recent CHE Price: $483.85
Average Analyst Price Target: n/a (11.81%)
CHE Market Cap: $7.25B
Expected Ex-Dividend Date for CHE stock: Aug 12 2022
Expected Payment Date for CHE stock: Sep 02 2022
Expected Dividend & Yield for CHE stock: 0.30%
Recent Analyst Action: Ben Hendrix, analyst at RBC Capital, reiterates coverage on Chemed (CHE) stock in the Healthcare sector with a Buy rating and a price target of $ 541 (1 week ago).
Click for full story on CHE stock >>--------------------------------------------------------------------------
Eli Lilly & Co
Symbol: LLY
Recent LLY Price: $301.17
Average Analyst Price Target: $354.90 (17.84%)
LLY Market Cap: $289.43B
Expected Ex-Dividend Date for LLY stock: Aug 12 2022
Expected Payment Date for LLY stock: Sep 09 2022
Expected Dividend & Yield for LLY stock: 1.21%
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on Eli Lilly & Co (LLY) stock in the Healthcare sector with a Buy rating and a price target of $ 348 (4 days ago).
Click for full story on LLY stock >>--------------------------------------------------------------------------
Novo Nordisk
Symbol: NVO
Recent NVO Price: $108.79
Average Analyst Price Target: $133.00 (22.25%)
NVO Market Cap: $243.36B
Expected Ex-Dividend Date for NVO stock: Aug 12 2022
Expected Payment Date for NVO stock: Aug 23 2022
Expected Dividend & Yield for NVO stock: 1.08%
Recent Analyst Action: Michael Leuchten, analyst at UBS, reiterates coverage on Novo Nordisk (NVO) stock in the Healthcare sector with a Sell rating and a price target of n/a (1 month ago).
Click for full story on NVO stock >>--------------------------------------------------------------------------
Organon
Symbol: OGN
Recent OGN Price: $31.69
Average Analyst Price Target: $37.33 (17.80%)
OGN Market Cap: $7.99B
Expected Ex-Dividend Date for OGN stock: Aug 12 2022
Expected Payment Date for OGN stock: Sep 15 2022
Expected Dividend & Yield for OGN stock: 3.57%
Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on Organon (OGN) stock in the Healthcare sector with a Hold rating and a price target of $ 37 (1 week ago).
Click for full story on OGN stock >>--------------------------------------------------------------------------
Teleflex
Symbol: TFX
Recent TFX Price: $253.87
Average Analyst Price Target: $293.00 (15.41%)
TFX Market Cap: $11.92B
Expected Ex-Dividend Date for TFX stock: Aug 12 2022
Expected Payment Date for TFX stock: Sep 15 2022
Expected Dividend & Yield for TFX stock: 0.55%
Recent Analyst Action: Jayson Bedford, analyst at Raymond James, reiterates coverage on Teleflex (TFX) stock in the Healthcare sector with a Buy rating and a price target of $ 266 (1 week ago).
Click for full story on TFX stock >>--------------------------------------------------------------------------
MiningAndMetalMovers.com keeps investors informed of the top moving stocks within the mining and metal sector. We provide investors with timely information regarding top moving stocks in the health tech sector sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MiningAndMetalMovers.com.